Everest Medicines Limited (HKG:1952)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
25.02
0.00 (0.00%)
Jul 30, 2026, 3:40 PM HKT

Everest Medicines Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,79413,06515,5926,6985,37510,326
Market Cap Growth
-62.03%-16.21%132.78%24.63%-47.95%-47.98%
Enterprise Value
6,78512,13213,6304,3063,7126,099
Last Close Price
25.0236.9848.4020.9017.3834.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
34.0995.03----
PS Ratio
4.636.8820.7348.28371.66155778.93
PB Ratio
1.492.213.601.220.841.43
P/TBV Ratio
2.463.658.062.491.452.46

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.576.3918.1231.04256.6592015.48

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.180.180.140.110.100.09
Net Debt / Equity Ratio
-0.34-0.34-0.25-0.36-0.20-0.36
Net Debt / EBITDA Ratio
8.558.551.532.280.802.04
Net Debt / FCF Ratio
11.5311.531.382.040.742.53
Asset Turnover
0.290.290.130.020.000
Inventory Turnover
22.6722.6711.012.250.77-
Quick Ratio
4.764.762.517.553.849.84
Current Ratio
4.894.892.547.633.929.95
Return on Equity (ROE)
-6.35%-6.35%-23.04%-15.90%-4.28%-15.84%
Return on Assets (ROA)
-3.65%-3.65%-9.09%-8.59%-13.24%-9.29%
Return on Capital Employed (ROCE)
-5.60%-5.60%-18.70%-15.60%-24.50%-16.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.77%-2.54%-7.11%-13.89%-5.20%-11.99%
FCF Yield
-1.98%-1.33%-5.08%-14.58%-31.80%-9.98%
Buyback Yield / Dilution
-4.84%-4.84%-2.51%-5.18%-1.49%-243.61%